Yes Lenzilumab , had good results with their very well “ picked “ patients ,
and primary endpoint chosen by “picking “ at ongoing study ...
The thing is I be happy when it will be approve , and I hope they will stop using this mostly worthless Remdesivir .,
Lenzilumab is not as good as Leronlimab , but it is better then anything we have now ..and entire world need more then just these two drugs .,
All imo
News 
Market Data 
Discover 
AI
